Neuropsychiatric syndromes associated with multiple sclerosis (Journal of Neurology (2007) 254, (SUPPL. 2) (73-76) DOI: 10.1007/s00415-007-2017-2);Neuropsychiatric syndromes associated with multiple sclerosis

Journal of Neurology

Volumn 254, Issue 2 SUPPL., 2007, Pages 309-

  Feinstein, Anthony ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Depression; Mania; Multiple sclerosis; Personality; Psychosis; Treatment

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; DEXTROMETHORPHAN; FLUOXETINE; LITHIUM CARBONATE; MOOD STABILIZER; OLANZAPINE; PLACEBO; QUETIAPINE; QUINIDINE; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

ARTICLE; BEHAVIOR CHANGE; BIPOLAR DISORDER; CLINICAL TRIAL; COGNITION; DISEASE ASSOCIATION; EMOTIONAL INCONTINENCE; EUPHORIA; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL HEALTH; MOOD DISORDER; MULTIPLE SCLEROSIS; PATHOLOGICAL CRYING; PATHOLOGICAL LAUGHTER; PATIENT COMPLIANCE; PERSONALITY DISORDER; PRIORITY JOURNAL; PSEUDOBULBAR AFFECT; PSYCHOSIS; PSYCHOTHERAPY; QUALITY OF LIFE;

BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; HUMANS; MULTIPLE SCLEROSIS; PSYCHOTIC DISORDERS;

EID: 34248562242     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0901-z     Document Type: Erratum

References (27)

1. Asghar A, Taber KH, Hurley RA, Hayman LA (2004) Pure neuropsychiatric presentation of multiple sclerosis. Am J Psychiatry 161:226-231
2. Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V et al. (2000) Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport 11:1153-1158
3. Beck AT, Steer RA, Brown GK (2000) BDI-Fast Screen for Medical Patients Manual. The Psychological Corporation, San Antonio, Tx
4. Benedict RH, Fishman I, McClellan MM, Bakshi R, Weinstock-Guttman B (2003) Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Multi Scler 9:393-396
5. Davison K, Bagley CR (1969) Schizophrenia-like psychoses associated with organic disorders off the central nervous system. A review of the literature. In: Herrington RN (ed) Current problems in neuropsychiatry. Hedley, Ashford, Kent, pp 113-184
6. Feinstein A (2000) Multiple sclerosis, depression and disease modifying drugs. Mult Scler 6:343-348
7. Feinstein A (2002) An examination of suicidal intent in patients with multiple sclerosis. Neurology 59:674-678
8. Feinstein A, du Boulay G, Ron MA (1992) Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. Br J Psychiatry 161:680-685
9. Feinstein A, Feinstein KJ, Gray T, O'Connor P (1997) The prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol 54:1116-1121
10. Feinstein A, O'Connor P, Gray T, Feinstein KJ (1999) The pathogenesis of pathological laughing and crying in multiple sclerosis: a role for the prefrontal cortex? Mult Scler 5:69-73
11. Feinstein A, Roy P, Lobaugh N, Feinstein KJ, O'Connor P (2004) Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 62:586-590
12. Flax JW, Gray J, Herbert J (1991) Effects of fluoxetine on patients with multiple sclerosis. Am J Psychiatry 148:1603
13. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Personal and family history of affective disorder. J Affect Disord 12:63-65
14. Lynch SG. Kroencke DC, Denney DR (2001) The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping and hope. Mult Scler 7:411-416
15. Minden SL, Schiffer RB (1990) Affective disorders in multiple sclerosis: Review and recommendations for clinical research. Arch Neurol 47:98-104
16. Mohr DC, Boudewyn AC, Goodkin D, Bostrom A, Epstein L (2001) Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group therapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 69:942-949
17. Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP et al. (2006) Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 59:780-787
18. Patten SB, Beck CA, Williams JVA, Barbui C, Metz LM (2003) Major depression in multiple sclerosis. A population-based perspective. Neurology 61:1524-1527
19. Patten SB, Svenson LW, Metz LM (2005) Psychotic disorders in MS: Population-based evidence of an association. Neurology 65:1123-1125
20. Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A (1997) Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 49:1105-1110
21. Rabins PV (1990) Euphoria in multiple sclerosis. In: Rao SM (ed) Neurobehavioral aspects of multiple sclerosis. Oxford University Press, New York, pp 180-185
22. Sadovnik AD, Eisen RN, Ebers GC, Paty DW (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology 41:1193-1196
23. Schiffer RB, Herndon RM, Rudick RA (1983) Treatment of pathologic laughter and weeping with amitriptyline. NEJM 312:1480-1482
24. Schiffer RB, Wineman NM (1990) Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147:1493-1497
25. Schubert RSB, Foliart RH (1993) Increased depression in multiple sclerosis: A meta-analysis. Psychosomatics 34:124-130
26. Seliger GM, Hornstein A, Flax J, Herbert J, Schroder K (1992) Fluoxetine improves emotional incontinence. Brain Inj 6:267-270
27. Stenager EN, Stenager E (1992) Suicide and patients with neurologic diseases. Methodologic problems. Arch Neurol 49:1296-1303